252 results
Page 5 of 13
8-K
obcyxh v049o
22 Jun 20
Material Modifications to Rights of Security Holders
4:18pm
8-K
EX-3.1
oignvxf985qheza
22 Jun 20
Material Modifications to Rights of Security Holders
4:18pm
8-K
EX-99.1
u6hjjtulw9nla
16 Jun 20
Entry into a Material Definitive Agreement
4:48pm
8-K
si7cnfs3
16 Jun 20
Entry into a Material Definitive Agreement
4:48pm
8-K
EX-99.1
7h0 cbm7sjibey6863
18 May 20
Adamis Pharmaceuticals Announces First Quarter 2020 Financial Results and Business Update
4:57pm
8-K
dlnz55917zk7 15e713
13 May 20
Adamis Pharmaceuticals Provides Update on SYMJEPI Products and Announces Distribution and Commercialization Agreement for SYMJEPI and ZIMHI Products
5:20pm
8-K
EX-99.1
z00j6b
13 May 20
Adamis Pharmaceuticals Provides Update on SYMJEPI Products and Announces Distribution and Commercialization Agreement for SYMJEPI and ZIMHI Products
5:20pm
8-K
EX-99.1
j49ch
30 Mar 20
Adamis Pharmaceuticals Announces 2019 Financial Results and Business Update
4:50pm
424B5
emeiyvb899jxr
24 Feb 20
Prospectus supplement for primary offering
5:16pm
8-K
EX-99.2
k0gfdyi3jcd15f5
21 Feb 20
Adamis Pharmaceuticals Announces Pricing of $6.7 Million Registered Direct Offering
5:24pm
8-K
EX-10.1
4sfuci
21 Feb 20
Adamis Pharmaceuticals Announces Pricing of $6.7 Million Registered Direct Offering
5:24pm
8-K
EX-99.1
1qq7l1sa c98
26 Dec 19
Adamis Pharmaceuticals Provides an Update on ZIMHI
4:59pm
8-K
EX-99.1
3tqsu9
25 Nov 19
Adamis Pharmaceuticals Receives a Complete Response Letter from the FDA Regarding ZIMHI
9:16am
8-K
EX-99.1
xosaz1jn6 uo02
12 Nov 19
Adamis Pharmaceuticals Announces Third Quarter 2019 Financial Results and Business Update
4:41pm
8-K
EX-99.1
0vpxr2rj9 f0
8 Aug 19
Adamis Pharmaceuticals Announces Second Quarter 2019 Financial Results and Business Update
4:55pm